9.63
4.00%
0.37
アフターアワーズ:
9.47
-0.16
-1.66%
前日終値:
$9.26
開ける:
$9.32
24時間の取引高:
2.17M
Relative Volume:
0.91
時価総額:
$1.10B
収益:
-
当期純損益:
$-119.76M
株価収益率:
-8.6757
EPS:
-1.11
ネットキャッシュフロー:
$-55.17M
1週間 パフォーマンス:
+10.06%
1か月 パフォーマンス:
+25.06%
6か月 パフォーマンス:
+102.31%
1年 パフォーマンス:
+306.33%
Applied Therapeutics Inc Stock (APLT) Company Profile
名前
Applied Therapeutics Inc
セクター
電話
212-220-9226
住所
545 FIFTH AVENUE, SUITE 1400, NEW YORK, NY
Applied Therapeutics Inc Stock (APLT) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2022-01-04 | ダウングレード | Barclays | Overweight → Equal Weight |
2021-08-27 | ダウングレード | Goldman | Neutral → Sell |
2021-06-25 | 再開されました | Goldman | Neutral |
2020-10-08 | 開始されました | Truist | Buy |
2020-04-22 | 開始されました | Goldman | Buy |
2020-02-27 | 開始されました | Barclays | Overweight |
2019-06-10 | 開始されました | Citigroup | Buy |
2019-06-10 | 開始されました | Cowen | Outperform |
2019-06-10 | 開始されました | Robert W. Baird | Outperform |
すべてを表示
Applied Therapeutics Inc (APLT) 最新ニュース
Applied Therapeutics to Present at the 2024 UBS Global Healthcare Conference - GlobeNewswire
Applied Therapeutics (NASDAQ:APLT) Sets New 12-Month HighHere's Why - MarketBeat
Applied Therapeutics stock hits 52-week high at $9.41 - Investing.com
Applied Therapeutics stock hits 52-week high at $9.41 By Investing.com - Investing.com UK
US FDA’s November Goal Dates Cannot Elevate 2024’s Novel Approvals To 2023 Levels - Citeline
Seven PDUFA dates on FDA’s November calendar - BioCentury
Biotech Stocks Facing FDA Decision In November 2024 - RTTNews
Applied Therapeutics (APLT) Upgraded to Buy: Here's What You Should Know - MSN
ImmunityBio (IBRX) Soars 26.4%: Is Further Upside Left in the Stock? - MSN
Is Applied Therapeutics (APLT) Outperforming Other Medical Stocks This Year? - Yahoo Finance
Trigg Minerals Announces Key AGM Resolutions - MSN
Trading (APLT) With Integrated Risk Controls - Stock Traders Daily
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Update - MarketBeat
OncoSil Medical Plans Major Stock Issuance - MSN
Applied Therapeutics (NASDAQ:APLT) versus Ironwood Pharmaceuticals (NASDAQ:IRWD) Head-To-Head Analysis - Defense World
Hennion & Walsh Asset Management Inc. Has $2.26 Million Holdings in Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics (NASDAQ:APLT) Shares Down 4.9%Here's What Happened - MarketBeat
William Blair Issues Pessimistic Outlook for APLT Earnings - Defense World
Q2 EPS Estimate for Applied Therapeutics Cut by Analyst - MarketBeat
Sharps Technology files to sell 259,092 shares of common stock for holders - MSN
Ardmore Shipping leads tanker stocks lower as Stifel downgrades, seeing softer rates - MSN
Invesco BulletShares 2024 High Yield Corporate Bond ETF declares monthly distribution of $0.1100 - MSN
Is the Options Market Predicting a Spike in American Healthcare REIT, Inc. (AHR) Stock? - MSN
Waste Connections Q3 2024 Earnings Preview - MSN
APLT Stock Soars 69% on Positive Update on Galactosemia Drug NDA - MSN
Viking Therapeutics Stock: Buy or Sell Before Q3 Earnings? - MSN
Is It Worth Investing in Viking Therapeutics (VKTX) Based on Wall Street's Bullish Views? - MSN
Analysts Set Applied Therapeutics, Inc. (NASDAQ:APLT) Price Target at $12.50 - Defense World
Applied Therapeutics (NASDAQ:APLT) Trading Down 2.2%Here's What Happened - MarketBeat
There is no doubt that Applied Therapeutics Inc (APLT) ticks all the boxes. - SETE News
Applied Therapeutics Inc’s Market Journey: Closing Strong at 9.14, Up 2.81 - The Dwinnex
Varonis Systems Inc [VRNS] Investment Appeal on the Rise - Knox Daily
Applied Therapeutics Inc (APLT) gets rating Initiated from William Blair - Knox Daily
Wedbush’s latest rating for SYRE stock - Knox Daily
Omega Healthcare Investors, Inc.’s latest rating changes from various analysts - Knox Daily
Analysts review Liberty Energy Inc’s rating - Knox Daily
Applied Therapeutics (NASDAQ:APLT) Shares Up 6.4%Should You Buy? - MarketBeat
Applied Therapeutics, Inc. (NASDAQ:APLT) Short Interest Up 14.2% in September - MarketBeat
APLT overperforms with a 4.51 increase in share price - US Post News
Brokerages Set Applied Therapeutics, Inc. (NASDAQ:APLT) Target Price at $12.50 - MarketBeat
23,476 Shares in Applied Therapeutics, Inc. (NASDAQ:APLT) Acquired by Algert Global LLC - Defense World
Applied Therapeutics Inc [APLT] Chief Financial Officer makes an insider purchase of 13,530 shares worth 78880.0. - Knox Daily
insider Hazelbaker Jill sale 40,000 shares of Uber Technologies Inc [UBER] - Knox Daily
Selling Buzz: Dyne Therapeutics Inc [DYN] Director Kersten Dirk sells 21,518 shares of the company - Knox Daily
A company insider recently sold 4,512 shares of Twilio Inc [TWLO]. Should You Sale? - Knox Daily
Atlas Energy Solutions Inc. [AESI] Member of 10% Owner Group makes an insider sale of 8,571 shares worth 184,191. - Knox Daily
Insider Selling: John Minardo, Ironwood Pharmaceuticals Inc [IRWD] Chief Legal Officer divested 9,910 shares - Knox Daily
Are Medical Stocks Lagging Applied Therapeutics (APLT) This Year? - Yahoo Finance
Sei Investments Co. Acquires Shares of 114,619 Applied Therapeutics, Inc. (NASDAQ:APLT) - MarketBeat
Applied Therapeutics Inc (APLT) can make a big difference with a little luck - SETE News
Applied Therapeutics Inc: Buy, Hold, or Sell? Analysts Weigh In Amid Market Challenges - The InvestChronicle
Applied Therapeutics Inc (APLT) 財務データ
収益
当期純利益
現金流量
EPS
Applied Therapeutics Inc (APLT) インサイダートレーディング
インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
---|---|---|---|---|---|---|---|
Perfetti Riccardo | Chief Medical Officer |
Aug 22 '24 |
Sale |
5.83 |
22,681 |
132,230 |
986,853 |
Shendelman Shoshana | President and CEO |
Aug 13 '24 |
Sale |
6.18 |
357,423 |
2,208,874 |
4,810,430 |
Shendelman Shoshana | President and CEO |
Aug 12 '24 |
Sale |
5.98 |
300,000 |
1,794,000 |
5,167,853 |
Shendelman Shoshana | President and CEO |
Aug 14 '24 |
Sale |
5.93 |
119,591 |
709,175 |
4,690,839 |
大文字化:
|
ボリューム (24 時間):